Goldman Sachs has appointed insiders William Connolly and Michael Voris as co-heads of Equity Capital Markets (ECM) in the ...
Barclays downgraded shares of Moderna (NASDAQ:MRNA – Free Report) from an overweight rating to an equal weight rating in a report published on Tuesday, Ratings reports. The firm currently has $45.00 ...
China is starting to see a rebound in M&As as government stimulus measures start to bear fruit and pressure from Donald Trump ...
EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...
CSL and Cochlear are two of Australia’s blue-chip healthcare stocks, stalwarts of many investors portfolios, whereas Pro ...
Investors seeking to outperform the market should focus their stock-picking efforts on volatile names in the consumer ...
Major indices delivered a mixed performance on Friday after Donald Trump announced new "reciprocal tariffs" on a number of ...
The Dow Jones Industrial Average shed 165.35 points, or 0.37%, closing at 44,546.08. The S&P 500 ticked down 0.01% to ...
Shares of Roku Inc (NASDAQ:ROKU) are up 14.5% in premarket trading, after the streaming giant shared smaller-than-expected ...
The company is now expecting 2025 revenue to range from $1.5 billion to $2.5 billion, with a midpoint of $2.0 billion, while FactSet is expecting $2.4 billion. Most of that will come in the second ...
The Hang Seng Tech Index jumped 5.6% to a three-year high at close, bringing the week's advance to 7.3% and recording a fifth ...
Moderna (NASDAQ:MRNA – Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on Friday, February 14th. Analysts expect the company to announce earnings of ($2.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results